Subscribe
The latest psychology and neuroscience discoveries.
My Account
  • Mental Health
  • Social Psychology
  • Cognitive Science
  • Psychopharmacology
  • Neuroscience
  • About
No Result
View All Result
PsyPost
PsyPost
No Result
View All Result
Home Exclusive Psychopharmacology

Does LSD induce genuine synesthesia — or something different?

by Eric W. Dolan
May 17, 2016
in Psychopharmacology
Share on TwitterShare on Facebook
Follow PsyPost on Google News

A new placebo-controlled study has confirmed that the psychedelic drug LSD can induce synesthesia-like experiences. But the preliminary research, published in the journal Neuropsychologia, raises questions about whether LSD produces “genuine” synesthesia.

Synesthesia occurs when a person experiences an overlap in their senses. A person experiencing synesthesia might be able to taste colors or see sounds.

“Genuine” synesthesia occurs when a specific perception (called the “inducer”) automatically provokes another specific perception (called the “concurrent”). In genuine synesthetes, this pairing between the inducer and the concurrent remains fairly consistent over time. People with grapheme-color synesthesia, for example, might see the color green whenever they see the number 6.

There have been anecdotal reports about LSD causing synesthesia ever since the psychedelic drug was first discovered by Albert Hofmann in the 1930s. Research from the 1950s and 1960s also suggested that LSD could induce synesthesia. But these initial studies had a number of methodological problems, causing researchers to remain uncertain about LSD’s potential to induce genuine synesthesia.

To start to reduce this uncertainty, a group of scientists from the United Kingdom, led by Devin B. Terhune of Goldsmiths, University of London (previously University of Oxford), recruited nine men and one woman for study on LSD and synesthesia.

The ten participants were all deemed to be physically and psychologically healthy, and had prior experience with psychedelic drugs. During an initial testing session, they were injected with a saline solution, which acted as a placebo, before completing psychological tests to measure synesthesia-like experiences. After five to seven days, the participants were invited back for a second session. But this time, they were injected with 40-80 micrograms of LSD.

Terhune and his colleagues employed two verified tests of synesthesia — a grapheme-color association test and a sound-color association test. But the researchers found that the effects of LSD did not meet two of the accepted criteria for genuine synesthesia — consistency and specificity. The specific graphemes and sounds did not produce specific color experiences, and the associations between graphemes, sounds and colors were not more consistent under LSD than placebo.

The type of synesthesia produced by LSD could be “qualitatively different” from genuine synesthesia, the researchers said.

However, it is also possible that the effects of LSD failed to meet the accepted criteria for genuine synesthesia because the study was statistically underpowered due to the small number of participants.

“The fact that we didn’t observe increased stimulus-color consistency under LSD is an important issue because consistency is the most widely-used criterion for congenital synesthesia. I tend to believe this data is reliable as it was in the opposite direction of what was predicted if LSD was producing genuine synesthesia,” Terhune explained to PsyPost via email. “The inducer specificity data is harder to interpret because it was in the predicted direction but still clearly non-significant. This places it more in ambiguous territory.”

LSD and other psychedelic drugs present a problem for synesthesia researchers. Genuine synesthesia is considered a reliable and consistent phenomenon. One specific perception consistently induces another specific perception. The tests designed to measure synesthesia reflect this consistency. But the synesthesia-like experiences produced by LSD appear to be inconsistent and transient.

“This is a difficult issue because standard criteria for synesthesia have served the field well and synaesthetes almost universally meet these criteria. Alternatively, it may be that current definitions of what qualifies as synesthesia are overly narrow. To be honest, we’re really not sure at this point which way to go on this,” Terhune told PsyPost.

The criteria for synesthesia may need to be updated, or the synesthesia-like experiences produced by LSD may need to be treated as a unique phenomenon.

“If they are qualitatively different, then yes, we’ll need to develop new ways to study the multisensory effects reported by people on LSD. Studying drug-induced synesthesia-like experiences may prove very challenging if the experiences are completely transient and not very reliable. It may be conceptually similar to studying hallucinations, which are difficult to reliably induce in a laboratory setting,” Terhune explained to PsyPost.

TweetSendScanShareSendPin1ShareShareShareShareShare

RELATED

Use of mescaline may facilitate unintended improvements in several psychiatric conditions, study suggests
Ayahuasca

Many ayahuasca users report challenging experiences—yet some are linked to better mental health

July 4, 2025

Are challenging ayahuasca experiences always harmful? Not necessarily, finds a new global survey. While some effects predict poorer mental health, others like visual distortions are linked to positive outcomes, highlighting the crucial role of context and individual vulnerability.

Read moreDetails
Taking medicinal cannabis oil for insomnia does not impair cognition on the following day
Cannabis

Cannabis oil might help with drug-resistant epilepsy, study suggests

July 2, 2025

Nineteen patients with drug-resistant epilepsy experienced seizure freedom after cannabis oil treatment, with a median seizure-free duration of 245 days. Five remained seizure-free for over a year, and most reported improved quality of life and reduced seizure frequency.

Read moreDetails
Psychedelic compound blurs boundary between self and others in the brain, study finds
Ayahuasca

Psychedelic compound blurs boundary between self and others in the brain, study finds

July 2, 2025

A recent study found that a DMT/harmine formulation blurs the brain’s distinction between self and other faces, disrupting self-referential processing while preserving recognition of familiar faces, suggesting a neural basis for psychedelic-induced ego dissolution.

Read moreDetails
Researchers identify neural mechanism behind memory prioritization
MDMA

New study reveals how MDMA rewires serotonin and oxytocin systems in the brain

June 30, 2025

Researchers found that MDMA reduces anxiety and enhances social behavior in zebrafish by altering key neurochemical systems. The drug suppressed serotonin signaling, boosted oxytocin receptor expression, and modulated brain signaling proteins involved in emotional regulation.

Read moreDetails
Stimulant medication improves working memory of children with ADHD, study finds
ADHD

New study exposes gap between ADHD drug use and safety research in children

June 30, 2025

A nationwide Finnish study shows that children with ADHD stay on medication for over three years on average. Yet, controlled safety data for these medications in children exists for only one year, highlighting a gap in long-term evidence.

Read moreDetails
Regular psychedelic users exhibit different brain responses to self-related thoughts, study finds
Neuroimaging

Regular psychedelic users exhibit different brain responses to self-related thoughts, study finds

June 28, 2025

A new study suggests that regular users of psychedelics may process self-related thoughts differently at both psychological and brain levels, revealing altered patterns of brain activity during self-reflection compared to non-users who intend to try psychedelics.

Read moreDetails
Can Acacia catechu and Scutellaria baicalensis extracts enhance brain function?
Dementia

Ashwagandha extract boosts memory and cognition in people with mild cognitive impairment, study finds

June 27, 2025

Researchers found that a standardized extract of ashwagandha improved memory, attention, and spatial reasoning in adults with mild cognitive impairment, outperforming a placebo in a two-month clinical trial with no reported side effects.

Read moreDetails
Psychedelic use linked to increased risk of unusual visual experiences
Ayahuasca

Study links moderate awe in psychedelic ayahuasca journeys to better well-being

June 21, 2025

A new study published in the Journal of Psychoactive Drugs suggests that while awe can be transformative during ayahuasca retreats, there’s a limit. Experiences marked by excessive vastness were linked to lower well-being, challenging assumptions about awe’s universal benefits.

Read moreDetails

SUBSCRIBE

Go Ad-Free! Click here to subscribe to PsyPost and support independent science journalism!

STAY CONNECTED

LATEST

Neuroscientists decode how people juggle multiple items in working memory

Inside the bored brain: Unlocking the power of the default mode network

Choline imbalance in the brain linked to with cognitive symptoms in young depression patients

Scientists who relocate more often start Nobel research up to two years earlier

Sedentary time linked to faster brain aging in older adults, study finds

People with short-video addiction show altered brain responses during decision-making

New study uncovers a surprising effect of cold-water immersion

Being adopted doesn’t change how teens handle love and dating

         
       
  • Contact us
  • Privacy policy
  • Terms and Conditions
[Do not sell my information]

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

Subscribe
  • My Account
  • Cognitive Science Research
  • Mental Health Research
  • Social Psychology Research
  • Drug Research
  • Relationship Research
  • About PsyPost
  • Contact
  • Privacy Policy